Tectonic Therapeutic (TECX) Income towards Parent Company (2017 - 2026)

Tectonic Therapeutic (TECX) has reported Income towards Parent Company for 10 consecutive years, with -$53.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Income towards Parent Company fell 236.16% year-over-year to -$53.8 million; the TTM figure through Mar 2026 stood at -$112.0 million (down 99.14% YoY), while the FY2025 annual figure was -$74.2 million, down 33.65% from the prior year.
• Income towards Parent Company fell to -$53.8 million in Q1 2026 per TECX's latest filing, from -$19.2 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$9.3 million in Q4 2023 and bottomed at -$53.8 million in Q1 2026.
• Historically, Income towards Parent Company has averaged -$20.5 million across 5 years, with a median of -$19.0 million in 2025.
• Annual changes were most pronounced in 2023 — Income towards Parent Company surged 64.08% — and 2026, when it plunged 236.16%.
• Tectonic Therapeutic's Income towards Parent Company stood at -$25.8 million in 2022, then soared by 64.08% to -$9.3 million in 2023, then dropped by 6.46% to -$9.9 million in 2024, then plunged by 94.71% to -$19.2 million in 2025, then plunged by 179.85% to -$53.8 million in 2026.
• Business Quant data shows TECX's Income towards Parent Company at -$53.8 million in Q1 2026, -$19.2 million in Q4 2025, and -$19.0 million in Q3 2025.